London specialist clinic Santis Health has received a 2026 Global Recognition Award for combining robotic prostatectomy, real-time pathology and multidisciplinary planning in prostate cancer care.

PROCEPT BioRobotics ® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient ...

Adding darolutamide (Nubeqa) to androgen deprivation therapy (ADT) and radiation therapy significantly improved metastasis-free survival in patients with very high-risk prostate cancer, according to ...

The LUNAR trial assessed secondary survival endpoints in patients with oligorecurrent prostate cancer receiving 177Lu-PNT2002 and radiotherapy.

Santis Health advances prostate cancer treatment through robotic surgery, intraoperative pathology, and multidisciplinary ...

Earlier this year, Morrisons became the first grocery chain to introduce a new toilet rule across all of its hundreds of ...

Proud to Share New PROTEUS Findings on Perioperative Treatment in High-Risk Prostate Cancer / A Douglas Laird, ADT, Alberto ...

Diagnosed in December 2022, medical professional Shailesh Pathak opted for non-surgical treatment over prostate removal due ...

Women with early-stage breast cancer could be spared multiple rounds of gruelling radiotherapy under a “breakthrough” cancer ...

A retrospective cohort study of 124 men with biopsy Gleason 6 prostate cancer found that elevated PSA density and perineural ...

Key Updates in GU Oncology From ESMO 2026 / bladder cancer, cancer, cancer care, Cancer research, cancer treatment, clinical ...